Weekly Roundup: March 15-19, 2021

March 19, 2021
Morgan Petronelli, Associate Editor

ICYMI, some of this week’s featured content includes a new podcast episode and stories on a new E-BPO for rosacea, a quick guide to regenerative aesthetic medicine, cutaneous side effects seen in COVID vaccine patients, plus more.

POLL: What do you think of teledermatology?

The Mainstream Patient: March 15, 2021

This week’s edition of The Mainstream Patient features stories on pore vacuums, psoriasis on POC skin, the difference between fillers and Botox, how to treat scars, plus more.

New E-BPO Improves Rosacea

This formulation could be first FDA-approved single-agent E-BPO prescription drug to treat rosacea.

Chin Augmentation: Implants vs Injectables

The decision between surgical and nonsurgical options for chin augmentation continues to be a debate, but according to Michael Somenek, MD, this can be easily settled with personalized patient consultation.

Optimize Risk, Management of Pigmented Lesions in Pediatric Patients

Diagnosis, risk assessment and treatment of congenital melanocytic nevi (CMN), as well as melanoma, require specific strategies for pediatric patients.

Quick Guide to Regulatory Issues for Regenerative Aesthetic Medicine

Expert offers tips on understanding and complying with regulations governing this growing sector.

The Cutaneous Connection: Episode 20- Tips for a Successful Match

In this episode, we discuss the residency match process with Jay Wofford, MD, including how the entire process works, tips on what to do and what not do, questions you should ask yourself and what to do if you don’t match.

Vaccine Patients Experiencing ‘Vaccine Arm’ Days After Injection

Increasing reports have surfaced of vaccine recipients experiencing delayed cutaneous side effects after receiving the first dose. Experts assure that while the delayed side effect is uncomfortable, it is temporary and can be treated at home.

Legal Eagle: Will OSHA Regulations Require Significant Changes in Running an Office?

Physicians have an obligation to create a hazard-free workplace, but the question is what legally constitutes a hazard?